Skip to main content
. 2022 Dec 13;12:1074538. doi: 10.3389/fonc.2022.1074538

Figure 2.

Figure 2

Overall survival (OS) in all patients was examined with Kaplan-Meier plots and log-rank tests. (A) Comparison of four groups (KRAS-G12D, KRAS-G12V, KRAS-G12R, KRAS-Q61) with KRAS mutations. (B) Comparison of patients with KRAS wild-type and those with KRAS mutations. Other groups included KRAS-G12D, KRAS-G12V, KRAS-G12R, and KRAS-Q61. (C) Intercomparison between patients with KRAS-G12D mutation and other patients. Other groups included KRAS wild-type, KRAS-G12V, KRAS-G12R, and KRAS-Q61. (D) Examination of mutations at codons 12 and 61. KRAS-G12D, KRAS-G12V, and KRAS-G12R were all part of the codon 12 group of KRAS. The KRAS-Q61 family consisted of four different variants (KRAS-Q61H, KRAS-Q61R, KRAS-Q61K, and KRAS-Q61L). WT, KRAS wild-type; HR, hazard ratio; The numbers in parentheses represent 95% confidence intervals.